Found: 30
Select item for more details and to access through your institution.
Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 259, doi. 10.1002/ejhf.2057
- By:
- Publication type:
- Article
Corrigendum to 'Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2020;22:1315–1341].
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 345, doi. 10.1002/ejhf.2152
- Publication type:
- Article
Current challenges for using the Kansas City Cardiomyopathy Questionnaire to obtain a standardized patient-reported health status outcome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Standardizing the standard: reporting health status in clinical trials.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 203, doi. 10.1002/ejhf.2117
- By:
- Publication type:
- Article
Use of biomarkers to diagnose and manage cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 217, doi. 10.1002/ejhf.2113
- By:
- Publication type:
- Article
Corrigendum to 'Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)' [Eur J Heart Fail 2020;22:1504-1524].
- Published in:
- 2021
- Publication type:
- corrected article
New effective treatment options reinforce disease awareness: the case of transthyretin cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 290, doi. 10.1002/ejhf.2111
- By:
- Publication type:
- Article
Failure of intravenous immunoglobulin to improve cardiac function in parvovirus B19-associated chronic dilated cardiomyopathy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Tafamidis is entering the clinical arena for the treatment of transthyretin‐related cardiomyopathy: certainties and unmet needs.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 286, doi. 10.1002/ejhf.2104
- By:
- Publication type:
- Article
COVID‐19 acute respiratory distress syndrome: intriguing haemodynamics of an intriguing syndrome.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 208, doi. 10.1002/ejhf.2087
- By:
- Publication type:
- Article
Dynamics of myocardial fibrosis after left ventricular assist device implantation: should speeding up the scar have us scared stiff?
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 335, doi. 10.1002/ejhf.2085
- By:
- Publication type:
- Article
Pulmonary artery pulsatility index predicts right ventricular myofilament dysfunction in advanced human heart failure.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 339, doi. 10.1002/ejhf.2084
- By:
- Publication type:
- Article
Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 302, doi. 10.1002/ejhf.2082
- By:
- Publication type:
- Article
How to ATTR-ACT the perfect match?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 264, doi. 10.1002/ejhf.2028
- By:
- Publication type:
- Article
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 277, doi. 10.1002/ejhf.2027
- By:
- Publication type:
- Article
Left ventricular systolic ejection time is an independent predictor of all‐cause mortality in heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 240, doi. 10.1002/ejhf.2022
- By:
- Publication type:
- Article
Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 231, doi. 10.1002/ejhf.2016
- By:
- Publication type:
- Article
Mechanical circulatory support does not reduce advanced myocardial fibrosis in patients with end‐stage heart failure.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 324, doi. 10.1002/ejhf.2021
- By:
- Publication type:
- Article
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 250, doi. 10.1002/ejhf.1974
- By:
- Publication type:
- Article
Viral presence‐guided immunomodulation in lymphocytic myocarditis: an update.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 211, doi. 10.1002/ejhf.1969
- By:
- Publication type:
- Article
Heart failure‐related hospitalisation and management during the COVID‐19 pandemic: a reflection. Reply.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 344, doi. 10.1002/ejhf.1939
- By:
- Publication type:
- Article
Heart failure‐related hospitalisation and management during the COVID‐19 pandemic: a reflection. Letter regarding the article 'The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic'
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 343, doi. 10.1002/ejhf.1931
- By:
- Publication type:
- Article
Do Cheyne and Stokes have an important message for modern-day patients with heart failure? Yes, they do.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Issue Information.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. i, doi. 10.1002/ejhf.1877
- Publication type:
- Article
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 201, doi. 10.1002/ejhf.1876
- By:
- Publication type:
- Article
Do chronic heart failure patients receive optimal decongestive interventions in a real‐life setting?: Reply.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 342, doi. 10.1002/ejhf.1859
- By:
- Publication type:
- Article
Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Do chronic heart failure patients receive optimal decongestive interventions in a real-life setting? Letter regarding the article 'Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry'.
- Published in:
- 2021
- By:
- Publication type:
- Letter